The Division of Allergy and Infectious Diseases at the University of Washington has trained 137 physician-scientists through continuous funding provided by this training grant since its inception in 1976. About 80% of these trainees remain in research positions. Many have achieved leadership positions such as six that became Deans or Associate Deans of Medicine, one that became a Department Chair, nine that became Division Heads, 37 full professors and 10 others with leadership positions. Trainees that have finished in the past 10 years have had remarkable early success in research careers, including >50% achieving research funding, >25% with K awards, and >90% publishing one or more papers related to their supported research. The continuing objective of the program is to provide post-doctoral training for physician-scientists committed to a research career in infectious diseases. Eight postdoctoral training stipends per year are requested; the same number as in the previous funding period. There are currently 46 participating mentors with $295 million annual direct research funding and outstanding mentorship records. Each trainee selects a mentor (or more than one) for detailed research training in one of six research tracks. All trainees complete a core curriculum consisting of required didactic, research and clinical activities. Many trainees elect to take course work at the University of Washington and an average of three a year seek a MPH or MS degree. The program generally requires three years of training, one clinical year supported by the hospitals, and two research years supported by this training grant.
Infectious diseases continue to extract a considerable social and financial toll even in developed countries due to factors such as emerging pathogens, AIDS or other immuno-compromising conditions and antimicrobial resistance; in fact, they represent the leading cause of morbidity and mortality worldwide. The training of new scientists-physicians who can elucidate the basic mechanisms of host defense is critical for the formulation of new and improved strategies to diagnose, treat and prevent infectious diseases.
|Simmons, Jason D; Stein, Catherine M; Seshadri, Chetan et al. (2018) Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection. Nat Rev Immunol 18:575-589|
|Goldberg, Drew W; Tenforde, Mark W; Mitchell, Hannah K et al. (2018) Neurological Sequelae of Adult Meningitis in Africa: A Systematic Literature Review. Open Forum Infect Dis 5:ofx246|
|Hahn, William O; Butler, Noah S; Lindner, Scott E et al. (2018) cGAS-mediated control of blood-stage malaria promotes Plasmodium-specific germinal center responses. JCI Insight 3:|
|Tenforde, M W; Longley, N; Meya, D B et al. (2018) Poor specificity of urinary cryptococcal antigen testing: Reply to Drain et al. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal. HIV Med 19:e47-e48|
|Shah, Javeed A; Musvosvi, Munyaradzi; Shey, Muki et al. (2017) A Functional Toll-Interacting Protein Variant Is Associated with Bacillus Calmette-Guérin-Specific Immune Responses and Tuberculosis. Am J Respir Crit Care Med 196:502-511|
|Mikacenic, Carmen; Price, Brenda L; Harju-Baker, Susanna et al. (2017) A Two-Biomarker Model Predicts Mortality in the Critically Ill with Sepsis. Am J Respir Crit Care Med 196:1004-1011|
|Bajema, Kristina L; Dalesandro, Mark F; Fredricks, David N et al. (2017) Disseminated coccidioidomycosis presenting with intramedullary spinal cord abscesses: Management challenges. Med Mycol Case Rep 15:1-4|
|Bajema, Kristina L; Pakzad-Vaezi, Kaivon; Hawn, Thomas et al. (2017) Tuberculous uveitis: association between anti-tuberculous therapy and clinical response in a non-endemic country. J Ophthalmic Inflamm Infect 7:19|
|Fisher, Cynthia E; Hohl, Tobias M; Fan, Wenhong et al. (2017) Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation. Blood 129:2693-2701|
|Bajema, Kristina L; Simonson, Paul D; Greninger, Alex L et al. (2017) Acute Liver Failure Due to Echovirus 9 Associated With Persistent B-Cell Depletion From Rituximab. Open Forum Infect Dis 4:ofx174|
Showing the most recent 10 out of 100 publications